Mind Medicine (MindMed) Inc. (MNMD) Reached A New High 1 time During The Past Five Days

As of Wednesday close, Mind Medicine (MindMed) Inc.’s (NASDAQ:MNMD) stock was down -$0.04, moving down -6.33 percent to $0.67. The average number of shares traded per day over the past five days has been 3,087,200 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.1055 fall in that time frame. In the last twenty days, the average volume was 2,622,435, while in the previous 50 days, it was 2,637,150.

Since last month, MNMD stock retreated -13.28%. Shares of the company fell to $0.6592 on 06/22/22, the lowest level in the past month. A 52-week high of $3.92 was reached on 01/03/22 after having rallying from a 52-week low of $0.70. Since the beginning of this year, MNMD’s stock price has dropped by -51.54% or -$0.7113, and marked a new high 1 time. However, the stock has declined by -82.94% since its 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Mind Medicine (MindMed) Inc. (MNMD) last reported insider trading activity 7 days ago on Jun 16. Barrow Robert, the Chief Executive Officer of the company, disposed of 21,275 shares for $0.70 on Jun 16. It resulted in a $14,892 divestment by the insider. Karlin Dan sold 9,555 shares at an average price of $0.82 on May 27. The insider now owns 4,077,719 shares following the transaction. On May 25, Chief Executive Officer Barrow Robert sold 18,415 shares at $0.77 apiece. The transaction was valued at $14,180.

Financial Health

Based on annual data, MNMD earned -$93.85 million in gross profit.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Mind Medicine (MindMed) Inc. to report -$0.05 quarterly earnings, the actual figure was -$0.04 per share. During the quarter, the company generated -$17.73 million in EBITDA. The liabilities of Mind Medicine (MindMed) Inc. were 12.43 million at the end of its most recent quarter ended March 30. The value of shareholders’ equity is $422.44 million.

Technical Picture

This quick technical analysis looks at Mind Medicine (MindMed) Inc.’s (MNMD) price momentum. With a historical volatility rate of 36.31%, the RSI 9-day stood at 25.56% on 22 June.

With respect to its five-day moving average, the current Mind Medicine (MindMed) Inc. price is down by -13.63% percent or -$0.1055. At present, MNMD shares trade -15.45% below its 20-day simple moving average and -26.99% percent below its 100-day simple moving average. However, the stock is currently trading approximately -31.02% below its SMA50 and -76.54% below its SMA200.

Stochastic coefficient K was 2.55% and Stochastic coefficient D was 2.55%, while ATR was 0.0650. Given the Stochastic reading of 2.43% for the 14-day period, the RSI (14) reading has been calculated as 32.78%. As of today, the MACD Oscillator reading stands at -0.0593, while the 14-day reading stands at -0.1368.

Analyst Ratings

ROTH Capital launched its rating on Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) to a Buy in a note to investors on May 04, 2022. Mind Medicine (MindMed) Inc. (MNMD) has been rated Buy by analysts. According to 0 brokerage firms, MNMD is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Mind Medicine (MindMed) Inc. stock as buy, with 5 recommending it as overweight.

With a median target price of $5.14, the current consensus forecast for the stock is $3.00 – $10.00. Based on these forecasts, analysts predict Mind Medicine (MindMed) Inc. (MNMD) will achieve an average price target of $5.69.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles

174452

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam